Liraglutide was approved by the FDA under the name Victoza as a Type 2 diabetes treatment in January 2010 and then rebranded as Saxenda for obesity treatment in December 2014
Were hopeful for the future, but were talking years down the track, and because the public and practitioners know about these medications, theyre the ones who are advocating for the Government to look into this to make access available for those who need [these medications] most, which are often the people who can least afford it. Dr South added that if Wegovy secures a listing on the PBS as a weight-loss treatment, GPs can be prepared for more patients asking about the drug
This article examines the evidence for Ozempic's effects on cholesterol, how it compares with established lipid therapies, and important considerations for patients with both diabetes and dyslipidaemia
Our study shows that adoption of GLP-1 agonists changes both the amount and types of food people eat, Lusk said
If more than 5 days have passed, they should skip the missed dose and administer the next dose on the regularly scheduled day